Rights and permissions
About this article
Cite this article
Is DOTS-plus worth it for TB in developing countries?. Inpharma Wkly. 1379, 5 (2003). https://doi.org/10.2165/00128413-200313790-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200313790-00010